Browsing Category
Vaccines
John Yang volunteered to participate in the phase 3 Moderna COVID-19 vaccine trial. The Moderna vaccine has been 94.5% effective and is waiting FDA approval. Yang chose to take part in the trial because he is considered high risk and would rather have the vaccine sooner rather than later. He!-->…
Read More...
Following the announcement of Pfizer's vaccine success last week, Moderna has announced its preliminary results. While Pfizer had a 90% effective vaccine, Moderna's vaccine had 94.5% efficacy. These vaccines are the first to be made of mRNA, and based on their data, suggest incredible potential for!-->…
Read More...
Amongst some devastating COVID-19 related news this past week—including record daily cases and 1,000+ daily coronavirus-related deaths in the U.S.—there is hope for an end to the pandemic. Pfizer and BioNTech have been developing a vaccine and conducting Phase 3 clinical trials in hopes of!-->…
Read More...
SARS-CoV-2, like many other pathogens, needs to be at a certain vaccine dose in order for it to trigger an infection and immune response in an infected individual. A low dose may allow an individual to respond to a virus successfully, while a dose that is too high can potentially make a person!-->…
Read More...
The CDC’s Advisory Committee on Immunization Practices met to discuss how to best distribute a COVID-19 vaccine once one is approved. They identified four groups that would have priority vaccination. The first group to be vaccinated would be health care personnel due to their close proximity and!-->…
Read More...
The University of Oxford and Astra Zeneca are collaborating on the development of a coronavirus vaccine. With recent evidence, their vaccine appears to be one of the frontrunners for a vaccine available by the end of the year. Recent studies showed that an immune response was developed in response!-->…
Read More...
Two COVID-19 vaccine trials are currently paused due to concerns about its side effects. AstraZeneca's U.S. trial of its vaccine has been stalled for over a month after two volunteers developed neurological conditions, though it is unconfirmed how the conditions arose. Likewise, this Monday,!-->…
Read More...
Many potential Covid-19 vaccines utilize oil from sharks called squalene. It is taken from shark livers and typically used as a moisturizing ingredient in cosmetics and as an immune system booster in flu and malaria vaccines. Conservationists warn that if the coronavirus vaccine with squalene is!-->…
Read More...
China is making bold promises in the race of developing a coronavirus vaccine. Chinese health officials state that the vaccine will be ready by the end of the year; China has also committed to sharing the vaccine with other countries, particularly low-income countries that it has ties with. Under!-->…
Read More...
China has already promised to have a vaccine ready by the end of the year and has committed to sharing the vaccine with certain nations. It has also joined COVID-19 Vaccine Global Access which is aiming to provide doses of the vaccine to the most vulnerable groups and health care workers. However!-->…
Read More...